Freenome: Sally Howard, Charles Mwangi, Julie Tran
Cancer liquid biopsy firm Freenome has made three executive appointments.
Sally Howard has joined the company as senior VP of regulatory and quality. A lawyer by training, she was most recently VP of regulatory affairs and quality at Adaptive Biotechnologies. She also used to be deputy commissioner at the US Food and Drug Administration and held various positions, including deputy general counsel and chief of staff, at the Department of Health and Human Services.
Charles Mwangi has been appointed as Freenome's CFO, joining the firm from Western Digital, where he was senior VP and CFO for the Flash division. Prior to that, he was senior VP and CFO at Cepheid, and before that, he held financial leadership roles at Lam Research, Diageo, Broadcom, and Affymetrix.
Julie Tran has joined the company as chief people officer. Previously, she was senior VP of human resources at Myovant Sciences, and before that, she held leadership positions at Raptor Pharmaceuticals, Johnson & Johnson, Medivation, and Ipsen.